supported by the National Natural Science Foundation of China (81572944, 21471033, 21877113 and 81971983);the CAS/SAFEA International Partnership Program for Creative Research Teams, the High-Level Entrepreneurship and Innovation Talents Projects in Fujian Province (2018-8-1);the FJIRSM&IUE Joint Research Fund (RHZX-2018-004)。
Escherichia coli(E. coli) DH5α has been recognized as a non-pathogenic bacterial strain with tumor colonization ability. However, whether such a bacteria-driven drug-delivery system can improve the targeting of tumor...